Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BOM/532041 stock hub

BOM/532041 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/532041is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

93.1M

Bombay Stock Exchange

Market data

Price

Recent price action with selectable time range.

BOM/532041BOM/532041

—

Loading chart…

In the news

Latest news · BOM/532041

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E58.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC4.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/532041 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

166

Groups with data

Currency

INR

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2
Employees Change	-1%
Employees Change Percent	-33.33
Enterprise value	INR 119.1M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	INR 93.1M
Price	INR 9.08
Price currency	INR
Rev Per Employee	5,676,000x
Sic	2836
Symbol	bom/532041
Website	https://www.hindustanbiosciences.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.59%
EV Earnings	80.51x
EV/EBIT	81x
EV/EBITDA	83.71x
EV/Sales	10.49x
P/B ratio	10.82x
P/E ratio	58.33x
P/S ratio	8.2x
PE Ratio3 Y	329.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.95%
EBITDA Margin	12.53%
Gross margin	39.31%
Gross Profit	INR 4.5M
Gross Profit Growth	39.91%
Gross Profit Growth3 Y	28.76%
Gross Profit Growth5 Y	-6.94%
Net Income	INR 1.5M
Net Income Growth	326.3%
Net Income Growth5 Y	32.6%
Pretax Margin	12.8%
Profit Margin	13.03%
Profit Per Employee	INR 739,500
Roa5y	-4.1
Roe5y	-17.7
ROIC	4.25
Roic5y	-7.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.77%
Cagr15y	9.49%
Cagr1y	20.76%
Cagr20y	0.29%
Cagr3y	19.5%
Cagr5y	12.9%
EPS Growth	376.1
EPS Growth5 Y	34.37
Revenue Growth	40.06x
Revenue Growth3 Y	28.59x
Revenue Growth5 Y	-8.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 163,000
Debt	INR 26.2M
Debt EBITDA	INR 18.39
Debt Equity	INR 3.04
Equity	INR 8.6M
Interest Coverage	735
Net Cash	INR -26M
Net Cash By Market Cap	INR -27.93
Net Debt EBITDA	INR 18.28
Net Debt Equity	INR 3.02
Tangible Book Value	INR 8.6M
Tangible Book Value Per Share	INR 0.88
WACC	0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	10.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	332.38%
1Y total return	20.75%
200-day SMA	7.63
3Y total return	70.68%
50-day SMA	8.36
50-day SMA vs 200-day SMA	50over200
5Y total return	83.43%
All Time High	106.7
All Time High Change	-91.49%
All Time High Date	2003-06-11
All Time Low	0.2
All Time Low Change	4,440%
All Time Low Date	2002-01-21
ATR	0.63
Beta	-0.72
Beta1y	-0.02
Beta2y	0.02
Ch YTD	72.3
High	9.15
High52	10.32
High52 Date	2025-05-30
High52ch	-12.02%
Low	8.66
Low52	5
Low52 Date	2025-12-29
Low52ch	81.6%
Ma50ch	8.65%
Price vs 200-day SMA	18.97%
RSI	55.08
RSI Monthly	55.29
RSI Weekly	58.51
Sharpe ratio	0.39x
Sortino ratio	0.66
Total Return	10.45%
Tr YTD	72.3
Tr15y	289.7%
Tr1m	12.38%
Tr1w	2.48%
Tr3m	11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 1.5M
Operating Income Growth	359
Operating Income Growth5 Y	12.84
Operating margin	12.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,666,144%
Shares Insiders	21.13%
Shares Out	10,250,800
Shares Qo Q	5.13%
Shares Yo Y	-10.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	10,625.6x
Bv Per Share	0.88
Ch10y	332.4
Ch15y	289.7
Ch1m	12.38
Ch1w	2.48
Ch1y	20.75
Ch20y	5.95
Ch3m	11
Ch3y	70.68
Ch5y	83.43
Ch6m	30.27
Change	-0.11%
Change From Open	-0.66
Close	9.09
Days Gap	0.55
Depreciation Amortization	-47,500
Dollar Volume	61,725.8
Earnings Date	2026-05-29
EBIT	INR 1.5M
EBITDA	INR 1.4M
EPS	INR 0.16
F Score	1
Fiscal Year End	March
Founded	1,991
Graham Number	1.7581
Graham Upside	-80.64
Income Tax	INR -26,000
Is Primary Listing	1
Last Earnings Date	2026-01-31
Last Report Date	2025-12-31
Lynch Fair Value	INR 3.89
Lynch Upside	-57.14
Ma150	7.36
Ma150ch	23.35%
Ma20	9.14
Ma20ch	-0.61%
Next Earnings Date	2026-05-29
Open	9.14
Position In Range	85.71
Price Date	2026-05-08
Price EBITDA	INR 65.43
Ptbv Ratio	10.82
Relative Volume	0.64x
Revenue	11,352,000x
Tax By Revenue	-0.23x
Tr20y	5.95%
Tr6m	30.27%
Volume	6,798

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/532041 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/532041 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/532041?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+21.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-10.5%

Negative means the company is buying back shares.

Technical

BOM/532041 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.1

Neutral momentum band

Price vs 200-day MA

+19.0%

50/200-day relationship not available

Beta (5Y)

-0.72

Less volatile than the market

Sharpe ratio

0.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/532041

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/532041 stock rating?

bom/532041 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/532041 analysis?

The full report lives at /stocks/bom/532041/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/532041?

The latest report frames bom/532041 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/532041 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.